In this exploratory study, we investigated four well-established biomarkers reflecting CNS injury and neurodegeneration-amyloid beta, GFAP, NfL, and p-tau181- in a cohort of patients with DM1, aiming to provide a more comprehensive preliminary characterization of CNS involvement in this multisystem disorder. This evidence concerns the gene NEFL and myotonic dystrophy type 1.